Buka, Richard J
Sutton, David J
Nicolson, Phillip LR
Funding for this research was provided by:
British Heart Foundation (British Heart Foundation)
Article History
Accepted: 4 January 2024
First Online: 15 February 2024
Declarations
:
: No ethical approval was required or sought.
: RJB has received honoraria from Bayer, Sobi, and Sanofi, and Takeda.DJS has received honoraria from Pfizer-BMS and Bayer.PLRN has received research grants from Novartis, Principia, Sanofi, and Rigel Pharmaceuticals and has received had honoraria from Bayer, Grifols and Takeda.RJB and PLRN have received an externally-sponsored research grant from AstraZeneca to audit the use of reversal agents for direct oral anticoagulant-associated bleeding across the UK.